Neurocognition in Schizophrenia
common.study.values.description
“Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia”
This application seeks to determine if neurophysiological metrics of memantine (MEM)-enhanced early auditory information processing (EAIP) in schizophrenia (SZ) mediate gains in auditory processing fidelity (APF) and auditory learning.
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-yes
common.study.methods.is-healthy-no
Drug - Memantine
To assess the acute effects of MEM (0 vs. 20 mg) on measures of auditory processing fidelity, auditory learning and EAIP, in AP-medicated adult SZ patients and HS.
Drug - Placebos
To assess the acute effects of MEM (0 vs. 20 mg) on measures of auditory processing fidelity, auditory learning and EAIP, in AP-medicated adult SZ patients and HS.
participant.views.study.view.additional
participant.views.study.view.scientific-title
Memantine Effects on Sensorimotor Gating and Neurocognition in Schizophrenia
common.study.values.clinical-trial-id
NCT03860597
participant.views.study.view.id
b4xvgb
